✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Saroja Pharma Industries India Ltd.

SAROJA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹16 Cr.
P/E
15.32

Saroja Pharma Industries India Ltd.

  • Saroja Pharma Ind
  • Starsource Multitrad
  • Emmessar Biotech&Nut

FAQs on Saroja Pharma Industries India Ltd. Shareprice

Saroja Pharma Ind has given lower returns compared to its competitors.
Saroja Pharma Ind has grown at ~-5.17% over the last 2yrs while peers have grown at a median rate of 8.66%

Saroja Pharma Ind is not expensive.
Latest PE of Saroja Pharma Ind is 15.32, while 3 year average PE is 20.51.
Also latest EV/EBITDA of Saroja Pharma Ind is 5.79 while 3yr average is 6.45.

View FAQ's On Business

Growth Table

  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Balance Sheet

  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Cash Flow

  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Quarterly Results

  • Saroja Pharma Industries India Ltd.
  • Starsource Multitrad
  • Emmessar Biotech&Nut

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Saroja Pharma Industries India Ltd. Financials

Balance sheet of Saroja Pharma Ind is moderately strong.

The net debt of Saroja Pharma Ind is decreasing.
Latest net debt of Saroja Pharma Ind is ₹8.37 Crs as of Sep-25.
This is less than Mar-25 when it was ₹8.83 Crs.

Yes, profit is increasing.
The profit of Saroja Pharma Ind is ₹1.27 Crs for TTM, ₹1.03 Crs for Mar 2025 and ₹0.88 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Saroja Pharma Ind latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech